On August 23, 2018, POLUS BioPharm Inc. (KOSE:A007630) closed the transaction. The company issued 29th series bonds. The company amended the terms of the transaction.

The company raised 28th series bonds for gross proceeds of KRW 13,000,000,000. The bonds are fully convertible into common shares of the company at a conversion price of KRW 15,437 per share. The company will now issue 842,132 shares upon conversion of bonds.

The transaction involved participation from Sky Savings Bank, Ltd for 2,000,000,000.